BioInvent Q1: Improved sentiment
Research Note
2020-04-28
10:03
Redeye stands by its base case of SEK 2.5 following the Q1 report. We view promising early data from BI-1206 in NHL and expected positive upcoming news flow from other projects as supportive for the shares.
NE
Niklas Elmhammer
Disclosures and disclaimers